Blog Posts in July, 2018

New Implantable Continuous Glucose Monitor Approved by FDA

The U.S. Food and Drug Administration has approved the Eversense® Continuous Glucose Monitoring (CGM) System from Sensionics Holdings Inc. for people with diabetes in the United States. The system is the first and only CGM system to feature an implantable glucose sensor and provide long-term continuous monitoring for up to three months. Technology in managing diabetes has literally exploded in the ...

Lemon Blueberry Almond Cookies